| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/22/1999 | EP0943620A2 Betulinic acid derivatives for inhibiting cancer growth |
| 09/22/1999 | EP0943616A1 Substituted imidazole derivatives and their use as cytokine inhibitors |
| 09/22/1999 | EP0943615A1 1,4-dihydropyridine derivatives |
| 09/22/1999 | EP0943609A1 Azetidine derivative, bifidobacterium division-promoting composition containing the same, and a process for production thereof |
| 09/22/1999 | EP0943606A1 Benzenesulfonamide derivatives and drugs containing the same |
| 09/22/1999 | EP0943339A2 Method of preventing allograft rejection |
| 09/22/1999 | EP0943333A1 Medicament for the prevention and/or treatment of breast cancer comprising an inhibitor of estrogen synthesis |
| 09/22/1999 | EP0943332A1 Prevention and treatment of adhesions |
| 09/22/1999 | EP0943331A2 Formulations containing oxaliplatin |
| 09/22/1999 | EP0943330A1 Patch |
| 09/22/1999 | EP0943329A1 Fluoxetine hydrochloride for decreasing hot flashes |
| 09/22/1999 | EP0943328A2 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 09/22/1999 | EP0943327A1 Medicinal composition |
| 09/22/1999 | EP0943323A1 Cosmetic or dermatological composition containing at least a natural or recombinant arachnida silk protein or an analogue |
| 09/22/1999 | EP0943322A1 Use of a cosmetic composition to prevent and treat the rosacea |
| 09/22/1999 | EP0943311A2 Method of inhibiting hair growth |
| 09/22/1999 | EP0943008A1 Metal mediated serine protease inhibitors |
| 09/22/1999 | EP0943005A1 Tissue specific and target rna-specific ribozymes as antimicrobial therapeutics against microbial pathogens |
| 09/22/1999 | EP0943003A1 Insulin-like growth factor i (igf-i) expression system and methods of use |
| 09/22/1999 | EP0942976A1 Human sqm1 protein homolog comprising a cell adhesion protein |
| 09/22/1999 | EP0942975A1 Glaucoma-associated protein and corresponding nucleic acid and their therapeutic and diagnostic uses |
| 09/22/1999 | EP0942960A1 Promotion of regeneration of organized tissues |
| 09/22/1999 | EP0942933A1 Human kdel receptor |
| 09/22/1999 | EP0942928A1 Subunit respiratory syncytial virus vaccine preparation |
| 09/22/1999 | EP0942924A2 METHODS AND COMPOUNDS FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 09/22/1999 | EP0942920A1 Steroid esters, method for the manufacture thereof and their pharmaceutical use |
| 09/22/1999 | EP0942919A2 Compound |
| 09/22/1999 | EP0942916A2 Nucleosides |
| 09/22/1999 | EP0942915A1 Pharmaceutical formulations |
| 09/22/1999 | EP0942913A1 Ethylenediaminetriacetic acid and n-acyl ethylenediaminetriacetic acid silver chelactants |
| 09/22/1999 | EP0942911A1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 09/22/1999 | EP0942910A1 1,4-diazabicyclo[2.2.2]oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 09/22/1999 | EP0942907A1 2r, 4s, s, r- and 2s, 4r, s, r-hydroxyitraconazole |
| 09/22/1999 | EP0942906A2 Compounds useful for inhibition of farnesyl protein transferase |
| 09/22/1999 | EP0942903A1 Aryl-substituted acrylamides with leukotriene b4 (ltb-4) receptor antagonist activity |
| 09/22/1999 | EP0942902A2 Novel immunotherapeutic imides/amides |
| 09/22/1999 | EP0942899A1 Manufacturing process of metoprolol |
| 09/22/1999 | EP0942896A1 Substituted phenols and thiophenols useful as antioxidant agents |
| 09/22/1999 | EP0942780A1 Coated particles, methods of making and using |
| 09/22/1999 | EP0942754A2 Conjugates useful in the treatment of prostate cancer |
| 09/22/1999 | EP0942746A1 Inhibition of invasive remodelling |
| 09/22/1999 | EP0942743A1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 09/22/1999 | EP0942741A1 Lectin compositions and uses thereof |
| 09/22/1999 | EP0942740A2 Combination therapy using a tnf binding protein for treating tnf-mediated diseases |
| 09/22/1999 | EP0942738A1 Polyethylene glycol esters of polyunsaturated fatty acids |
| 09/22/1999 | EP0942737A1 Long chain carboxybetaines in antimicrobial formulations |
| 09/22/1999 | EP0942736A1 Methods of prevention and treatment of ischemic damage |
| 09/22/1999 | EP0942735A1 Use of nk-1 receptor antagonists for treating schizophrenic disorders |
| 09/22/1999 | EP0942734A1 Use of nk-1 receptor antagonists for treating severe anxiety disorders |
| 09/22/1999 | EP0942733A1 Use of nk-1 receptor antagonists for treating cognitive disorders |
| 09/22/1999 | EP0942732A1 Use of nk-1 receptor antagonists for treating movement disorders |
| 09/22/1999 | EP0942731A1 Use of nk-1 receptor antagonists for treating substance use disorders |
| 09/22/1999 | EP0942730A1 Use of nk-1 receptor antagonists for treating bipolar disorders |
| 09/22/1999 | EP0942729A1 Use of nk-1 receptor antagonists for treating stress disorders |
| 09/22/1999 | EP0942728A1 Use of nk-1 receptor antagonists for treating sexual dysfunction |
| 09/22/1999 | EP0942727A1 Transdermal delivery device for azapirone compounds |
| 09/22/1999 | EP0942726A2 Use of aminopiperazine derivatives |
| 09/22/1999 | EP0942725A1 Use of cis-hydroxyitraconazole in order to avoid side-effects of itraconazole and hydroxyintraconazole |
| 09/22/1999 | EP0942724A2 Gel formulations for topical drug delivery |
| 09/22/1999 | EP0942723A1 4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators |
| 09/22/1999 | EP0942722A1 Tetrahydro-beta-carboline compounds |
| 09/22/1999 | EP0942721A1 Pharmaceutical composition |
| 09/22/1999 | EP0942720A1 Use of metal complexes to treat gastrointestinal infections |
| 09/22/1999 | EP0942719A1 Verapamil as a medicament for the treatment of angina |
| 09/22/1999 | EP0942718A1 Coated trimebutine maleate tablet |
| 09/22/1999 | EP0942717A2 Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein |
| 09/22/1999 | EP0942716A1 Composition for transdermal delivery of drugs |
| 09/22/1999 | EP0942714A1 A product, a method for its production, and its use |
| 09/22/1999 | EP0942697A1 Fatty acid esters of lactic acid salts as permeation enhancers |
| 09/22/1999 | EP0873050A4 Pharmaceutical compositions for prevention and treatment of ulcerative colitis |
| 09/22/1999 | EP0813531B1 Antitumour isocoumarins |
| 09/22/1999 | EP0788355B1 Use of intravenously administered iron in the therapy of tumoral and infectious diseases |
| 09/22/1999 | EP0773963B1 Gas phase polymerization process |
| 09/22/1999 | EP0772615B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES, PREPARATION THEREOF AND DRUGS CONTAINING SAME |
| 09/22/1999 | EP0726764B1 Multilamellar liposomal arachidonic acid metabolite formulations |
| 09/22/1999 | EP0722323B1 Compositions containing troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence |
| 09/22/1999 | EP0706507B1 Salmeterol xinafoate with controlled particle size |
| 09/22/1999 | EP0674515B1 The use of carbostyril derivatives for the preparation of a medicament for the inhibition of Interleukin-8 |
| 09/22/1999 | EP0663900B1 Metal-oxime chelates for use as radiopharmaceutical agents |
| 09/22/1999 | EP0655063B1 Ethynyl alanine amino diol compounds having a piperazinyl-terminated group or a piperazinyl-alkylamino-terminated group for treatment of hypertension |
| 09/22/1999 | EP0639971B1 Therapeutic combinations |
| 09/22/1999 | EP0620741B1 Cytotoxic drug therapy |
| 09/22/1999 | EP0517836B1 Method and product for promoting hair growth and treating skin conditions |
| 09/22/1999 | CN1229438A Erythromycins and process for their preparation |
| 09/22/1999 | CN1229436A Antigen binding fragments that specifically detect cancer cells, nucleotindes encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 09/22/1999 | CN1229412A Inhibitors of interleukin-1'beta' converting emzyme |
| 09/22/1999 | CN1229411A Crystal form I of clarithromycin |
| 09/22/1999 | CN1229408A Dihydroindole derivatives useful as 5-HT-2C receptor antagonists |
| 09/22/1999 | CN1229407A Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 09/22/1999 | CN1229405A Novel acetamide derivatives and protease inhibitors |
| 09/22/1999 | CN1229367A Novel adsorbent |
| 09/22/1999 | CN1229359A Dendritic cell stimulatory factor |
| 09/22/1999 | CN1229356A Water-soluble vitamin composition that provides excellent tablets and process for producing the same |
| 09/22/1999 | CN1229085A Beta,beta-disubstituted derivatives of 9-deoxo-9a-N-ethenyl-9a-homoerythromycin A |
| 09/22/1999 | CN1229084A Unsaturated phosphate derivatives of purines and pyrimidines |
| 09/22/1999 | CN1229083A Novel phosphononosulfonate compounds and its pharmaceutical compositions |
| 09/22/1999 | CN1229082A Amine compound and its acid addition salt |
| 09/22/1999 | CN1229080A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 09/22/1999 | CN1229079A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 09/22/1999 | CN1229078A Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |